Cargando…
Bivalirudin vs. Enoxaparin in Intubated COVID-19 Patients: A Pilot Multicenter Randomized Controlled Trial
(1) Background: In COVID-19 patients, the occurrence of thromboembolic complications contributes to disease progression and mortality. In patients at increased risk for thrombotic complications, therapeutic enoxaparin should be considered. However, critically ill COVID-19 patients could develop resi...
Autores principales: | Garofalo, Eugenio, Cammarota, Gianmaria, Neri, Giuseppe, Macheda, Sebastiano, Biamonte, Eugenio, Pasqua, Pino, Guzzo, Maria Laura, Longhini, Federico, Bruni, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604898/ https://www.ncbi.nlm.nih.gov/pubmed/36294312 http://dx.doi.org/10.3390/jcm11205992 |
Ejemplares similares
-
Characteristics of unvaccinated and vaccinated critically ill COVID-19 patients in calabria region (Italy): A retrospective study
por: Bruni, Andrea, et al.
Publicado: (2022) -
Benefits of secretion clearance with high frequency percussive ventilation in tracheostomized critically ill patients: a pilot study
por: Garofalo, Eugenio, et al.
Publicado: (2023) -
Aggregometry and thromboelastography to identify the timing to trach a COVID‐19 patient receiving both antiplatelet therapy and enoxaparin
por: Tescione, Marco, et al.
Publicado: (2021) -
COVID-19: High-JAKing of the Inflammatory “Flight” by Ruxolitinib to Avoid the Cytokine Storm
por: Botta, Cirino, et al.
Publicado: (2021) -
Oxygenation strategies during flexible bronchoscopy: a review of the literature
por: Pelaia, Corrado, et al.
Publicado: (2021)